Management of diabetes mellitus in the elderly

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 18, Issue 2, 2011, Pages 148-152

  Chiniwala, Niyati ^a   Jabbour, Serge ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

diabetes; elderly; geriatric syndromes; management

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; EXENDIN 4; GLIBENCLAMIDE; GLIPIZIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; LOW DENSITY LIPOPROTEIN; MEGLITINIDE; METFORMIN; MIGLITOL; NICOTINIC ACID; PIOGLITAZONE; PRAMLINTIDE; REPAGLINIDE; STATIN;

AGED; ALCOHOL ABUSE; ARTICLE; BLOOD GLUCOSE MONITORING; CATARACT; CHRONIC PAIN; COGNITION; CREATININE CLEARANCE; DEPRESSION; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; EXECUTIVE FUNCTION; FALLING; FLATULENCE; GASTROINTESTINAL SYMPTOM; GENETIC HETEROGENEITY; GLAUCOMA; GLYCEMIC CONTROL; HEALTH CARE; HEALTH STATUS; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING HOME; PAIN; PHYSICAL ACTIVITY; PHYSICIAN; POLYPHARMACY; PREVALENCE; URINE INCONTINENCE; VOMITING;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS; GERIATRIC ASSESSMENT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 79952388665     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283444ba0     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2008.
2. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32:287.
3. Sloan FA, Bethel MA, Ruiz D Jr, et al. The growing burden of diabetes mellitus in the U.S. elderly population. Arch Intern Med 2008; 168:192-199. (Pubitemid 351185887)
4. Zhang X, Decker FH, Luo H, et al.Trends in the prevalence and co-morbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004. J Am Geriatr Soc 2010; 58:724.
5. Bethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med 2007; 167:921.
6. Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51:S265.
7. Cayea D, Boyd C, Durso S. Individualising therapy for older adults with diabetes mellitus. Drugs Aging 2007; 10:851-863. (Pubitemid 47553793)
8. Mooradian AD, Perryman K, Fitten J, et al. Cortical function in elderly non-insulin-dependent diabetic patients. Arch Intern Med 1988; 148:2369.
9. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2010; 33(Suppl 1):S11-S61.
10. Ben-Ami H, Nagachandran P, Mendelson A, et al. Drug-induced hypoglyce-mic coma in 102 diabetic patients. Arch Intern Med 1999; 159:281-284. (Pubitemid 29075648)
11. Shorr RI, Ray WA, Daugherty JR, et al. Incidence and riskfactorsforserious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157:1681-1686. (Pubitemid 27327403)
12. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301:1565.
13. Adler GK, Bonyhay I, Failing H, et al. Antecedent hypoglycemia impairs autonomic cardiovascularfunction: implicationsfor rigorousglycemiccontrol. Diabetes 2009; 58:360.
14. Miller CK, Edwards L, Kissling G, Sanville L Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial. Prev Med 2002; 34:252.
15. Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31(Suppl 1):S61.
16. Neumiller JJ, Setter SM. Pharmacologic management of the older patient with type 2 diabetes mellitus. Am J Geriatr Pharmacother 2009; 7:324.
17. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ 2003; 326:4.
18. van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997; 50:735-741. (Pubitemid 27341824)
19. Shorr RI, Ray WA, Daugherty JR, et al. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996; 44:751-755. (Pubitemid 26238715)
20. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33:278-285. (Pubitemid 15087125)
21. Scheen AJ. Drug interactions of clinical importance with antihyperglycaemic agents: an update. Drug Saf 2005; 28:601-631. (Pubitemid 41003048)
22. Papa G, Fedele V, Rizzo MR, et al. Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: a randomized, open-label, two-period, cross-over trial. Diabetes Care 2006; 29:1918.
23. Marbury TC, Ruckle JL, Hatorp V, et al. Pharmacokinetics of repaglinide in subjects with renal impairment Clin Pharmacol Ther 2000; 67:7-15. (Pubitemid 30078382)
24. Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use,fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care 2004; 27:256-263. (Pubitemid 38196741)
25. Coniff RF, Shapiro JA, Seaton TB, et al. Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbuta-mide-plus-acarbose in noninsulin dependent diabetes mellitus. Am J Med 1995; 98:443-451.
26. Exenatide (Byetta) for type 2 diabetes. Med Lett Drugs Ther 2005; 47 (1210):45-46.
27. Barnett A. DPP-4 inhibitors and theirpotential role in the management of type 2 diabetes. Int J Clin Pract 2006; 60:1454-1470. (Pubitemid 44560347)
28. Shorr RI, Franse LV, Resnick HE, et al. Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc 2000; 48:264-267. (Pubitemid 30164208)
29. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276:1886-1892. (Pubitemid 26419185)
30. Cayea D, Durso S. Management of diabetes mellitus in the nursing home. Ann Long-Term Care 2008; 16 (Suppl).